Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
about
Unexploited Antineoplastic Effects of Commercially Available Anti-Diabetic DrugsMetformin and the risk of cancer: time-related biases in observational studiesInositols in the Treatment of Insulin-Mediated DiseasesDissecting the Dual Role of AMPK in Cancer: From Experimental to Human StudiesEffect of metformin on cancer risk and treatment outcome of prostate cancer: a meta-analysis of epidemiological observational studiesPreoperative glycemic control status as a significant predictor of biochemical recurrence in prostate cancer patients after radical prostatectomyEffect of metformin on prostate cancer outcomes after radical prostatectomyMetformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality.Diabetes medications and cancer risk: review of the literatureDiabetes and cancer: Associations, mechanisms, and implications for medical practice.The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myelomaMetformin and cancer.Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case SeriesImpact of metformin on clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.Metformin: multi-faceted protection against cancer.Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis.Therapeutic metformin/AMPK activation blocked lymphoma cell growth via inhibition of mTOR pathway and induction of autophagy.The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate CancerDifferential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells.Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer.Metformin therapy and prostate cancer risk: a meta-analysis of observational studies.Anti-tumor effects of metformin on head and neck carcinoma cell lines: A systematic reviewThe impact of cow's milk-mediated mTORC1-signaling in the initiation and progression of prostate cancerTR4 Nuclear Receptor Alters the Prostate Cancer CD133+ Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene ExpressionNew players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationMolecular pathways: adiponectin and leptin signaling in cancer.Randomized Trials Built on Sand: Examples from COPD, Hormone Therapy, and Cancer.Association between metformin therapy and mortality after breast cancer: a population-based study.Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis.Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2.Metformin effects revisited.A PET-compatible tissue bioreactor for research, discovery, and validation of imaging biomarkers and radiopharmaceuticals: system design and proof-of-concept studies.The Effect of Metformin and GANT61 Combinations on the Radiosensitivity of Prostate Cancer Cells.Diabetes, cancer, and metformin: connections of metabolism and cell proliferation.Diabetes and cancer relationships.The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus.Repositioning metformin in cancer: genetics, drug targets, and new ways of delivery.A new dawn for the use of thiazolidinediones in cancer therapy.Cancer cachexia and diabetes: similarities in metabolic alterations and possible treatment.
P2860
Q26750845-DFCC1FED-E279-4EA2-A899-476DE60F102DQ26999266-4988DA4B-EFFA-4D5A-B50D-7A07E2823998Q28077870-CB8EA64E-9474-4FC3-9CAA-1973FB058302Q28081491-FB423EE1-0BDD-41F4-AB23-4402A3F1C2F9Q28542914-A6010F74-B461-4F46-8529-CA0FEDC0EDC6Q28546623-B4FFBEA8-B2FC-41FB-94BD-D23268CF9C34Q33551333-7D4F274C-AB94-41DF-B645-369961460FCDQ33668168-096FCF58-2E2C-4717-8E25-8075D078E128Q33714881-4FE4D37C-8F7B-4EA9-921E-4727E24ADD40Q33759594-449ACEA8-A62A-4466-B77A-21A373E81B05Q33994341-35683538-EE0A-4E60-B083-33A1333CE8C2Q34159241-801759EC-DE10-40E1-8BE9-FD6177EB7D08Q35125031-169C569C-BF68-4A0C-BCD0-2C29B46178C3Q35226909-F62B9235-9E5B-4C73-9902-428D0C01A8F5Q35558619-4D9316AD-BC71-47B2-84A4-5FC0B27407EFQ35764409-890C4EAD-A4C2-4C35-9028-DB76FBC3BE03Q35842470-14A6062A-7074-465F-869D-F72A3600941BQ35865232-EFE2930B-6A74-4586-A545-E5358E7D1BB0Q35882782-FBBADF71-C749-4313-BAAB-7370A6AB1039Q36059702-F1B4F6C4-3269-46B1-923A-3ACAC93F009DQ36070998-739E6358-1137-4907-B4AB-EEFFC6D4F1BBQ36182935-1D1C4247-6F35-4B7E-8F28-41BA7FF14A8CQ36327585-1A804C5E-75BE-40A3-A7E3-804AD0C1186EQ36402333-D32EB75D-7F81-499F-82D4-E41C9218F292Q36439839-3E4EB216-C539-43D2-B0D7-698A73D0A0A7Q36734036-2DA997F5-A558-4330-91B7-7F0BC6C03DD5Q36778002-54B85BD9-5A2B-457D-BE8F-6ECDED68A638Q36919212-79A6D306-3DD8-4624-8620-C608F4E1FD34Q37193432-6D6FED71-94AB-417B-BC9D-744788AEA3C7Q37404368-E52A133C-FD3F-4A75-9632-29F392EA5C71Q37428521-8A3BFF72-5066-470B-930C-08EEF689C97FQ37554697-8928BDD9-6B1C-44C5-A1F9-10F5D60D7923Q37677560-9E86C01B-A83D-42AF-A300-0DD36D338447Q37690270-45D7F5C0-D896-4C1A-BB83-591D90F505F8Q37972673-8D0D9FF7-163B-4C58-8C99-6E97556A0CDBQ38097984-69CC5289-B957-4C1A-ABA5-88239A3EBA03Q38102596-B696901D-8097-4D90-BCB5-1389822994F1Q38185970-0B2ED745-4CE4-46EF-A9ED-1BE683013554Q38193545-24517D11-2C15-4F3F-80F8-7488D883DCE1Q38215557-A30381A0-FB2C-41C3-9DC0-B374F8ED24D4
P2860
Thiazolidinediones and metformin associated with improved survival of diabetic prostate cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Thiazolidinediones and metform ...... etic prostate cancer patients.
@ast
Thiazolidinediones and metform ...... etic prostate cancer patients.
@en
type
label
Thiazolidinediones and metform ...... etic prostate cancer patients.
@ast
Thiazolidinediones and metform ...... etic prostate cancer patients.
@en
prefLabel
Thiazolidinediones and metform ...... etic prostate cancer patients.
@ast
Thiazolidinediones and metform ...... etic prostate cancer patients.
@en
P2093
P2860
P356
P1433
P1476
Thiazolidinediones and metform ...... betic prostate cancer patients
@en
P2093
P2860
P304
P356
10.1093/ANNONC/MDR020
P577
2011-03-17T00:00:00Z